• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受抗精神病药物治疗的智力迟钝者的行为障碍

Behavior disorders in persons with mental retardation receiving antipsychotic medication.

作者信息

Ono Y

机构信息

Wakayama Prefecture Children and Disabled Persons' Counseling Center, Japan.

出版信息

Res Dev Disabil. 1998 Mar-Apr;19(2):123-30. doi: 10.1016/s0891-4222(97)00046-2.

DOI:10.1016/s0891-4222(97)00046-2
PMID:9547524
Abstract

The behavior disorders of mentally retarded individuals receiving antipsychotic medication and the relationship between behavior disorders and the daily dose of drug were investigated. Of 355 residents of residential facilities in Wakayama Prefecture, Japan (age range, 7-64 years), the problem behaviors of 54 subjects receiving antipsychotic drugs were compared to those of 52 subjects receiving anticonvulsants and of 202 subjects without any medication at all, using the Japanese version of the Aberrant Behavior Checklist (ABC-J). All five subscale scores of the ABC-J were significantly higher for the antipsychotic group than for those of the other groups, whereas only the Irritability subscale was prominent in the subjects receiving anticonvulsants. The mean chlorpromazine equivalent dose was higher in the subjects with severe/profound disability than in those with mild/moderate disability and correlated with the Hyperactivity subscale scores. The problem behaviors of individuals with mental retardation prescribed antipsychotic drugs were more severe than those without medication; more severe disability and higher Hyperactivity scores were associated with dose of antipsychotic drugs.

摘要

对接受抗精神病药物治疗的智障人士的行为障碍以及行为障碍与药物日剂量之间的关系进行了调查。在日本和歌山县居住设施中的355名居民(年龄范围为7至64岁)中,使用日语版异常行为检查表(ABC-J),将54名接受抗精神病药物治疗的受试者的问题行为与52名接受抗惊厥药物治疗的受试者以及202名未接受任何药物治疗的受试者的问题行为进行了比较。抗精神病药物组的ABC-J所有五个子量表得分均显著高于其他组,而接受抗惊厥药物治疗的受试者中只有易激惹性子量表得分突出。重度/极重度残疾受试者的氯丙嗪等效剂量均值高于轻度/中度残疾受试者,且与多动性子量表得分相关。服用抗精神病药物的智障人士的问题行为比未服药者更严重;更严重的残疾和更高的多动得分与抗精神病药物剂量有关。

相似文献

1
Behavior disorders in persons with mental retardation receiving antipsychotic medication.接受抗精神病药物治疗的智力迟钝者的行为障碍
Res Dev Disabil. 1998 Mar-Apr;19(2):123-30. doi: 10.1016/s0891-4222(97)00046-2.
2
Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.抗精神病药物撤药后,成年智障患者攻击和破坏性行为的复发预示着十年后会使用精神药物。
J Clin Psychiatry. 2006 Aug;67(8):1272-7. doi: 10.4088/jcp.v67n0815.
3
Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital study.智障患者抗精神病药物剂量的减少。一项医院研究。
Br J Psychiatry. 1990 Jul;157:101-6. doi: 10.1192/bjp.157.1.101.
4
Results of barbiturate antiepileptic drug discontinuation on antipsychotic medication dose in individuals with intellectual disability.
J Intellect Disabil Res. 2000 Apr;44 ( Pt 2):155-63. doi: 10.1046/j.1365-2788.2000.00273.x.
5
Tranquilizer reduction trials in a residential program for persons with mental retardation.针对智力障碍者的住院项目中的镇静剂减量试验。
Hosp Community Psychiatry. 1993 Nov;44(11):1100-2. doi: 10.1176/ps.44.11.1100.
6
Factor validity and reliability for the Aberrant Behavior Checklist-Community in a Japanese population with mental retardation.日本智障人群中社区版异常行为检查表的因子效度和信度
Res Dev Disabil. 1996 Jul-Aug;17(4):303-9. doi: 10.1016/0891-4222(96)00015-7.
7
Neuroleptic and antiepileptic treatment in the mentally retarded.智障者的抗精神病药物与抗癫痫药物治疗
Seizure. 1993 Sep;2(3):205-11. doi: 10.1016/s1059-1311(05)80129-3.
8
Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders.评估非典型抗精神病药物在轻度智力发育迟缓合并精神疾病的成年人中的效用。
J Clin Psychiatry. 2005 Jan;66(1):52-62. doi: 10.4088/jcp.v66n0108.
9
An Open-Label Discontinuation Trial of Long-Term, Off-Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure.一项针对智力障碍者长期、标签外使用抗精神病药物的开放性停药试验:成功和失败的决定因素。
J Clin Pharmacol. 2018 Nov;58(11):1418-1426. doi: 10.1002/jcph.1271. Epub 2018 Jun 19.
10
Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.奥氮平治疗成年智力残疾者的自伤、攻击和破坏性行为:一项回顾性、开放标签、自然主义试验。
J Clin Psychiatry. 2003 Oct;64(10):1258-65. doi: 10.4088/jcp.v64n1018.